These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 24446520)

  • 1. TNF-α-dependent hematopoiesis following Bcl11b deletion in T cells restricts metastatic melanoma.
    Uddin MN; Zhang Y; Harton JA; MacNamara KC; Avram D
    J Immunol; 2014 Feb; 192(4):1946-53. PubMed ID: 24446520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD5
    Hatano S; Murakami T; Noguchi N; Yamada H; Yoshikai Y
    Cell Rep; 2017 Oct; 21(5):1191-1202. PubMed ID: 29091759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-specific clonal expansion and cytolytic effector function of CD8+ T lymphocytes depend on the transcription factor Bcl11b.
    Zhang S; Rozell M; Verma RK; Albu DI; Califano D; VanValkenburgh J; Merchant A; Rangel-Moreno J; Randall TD; Jenkins NA; Copeland NG; Liu P; Avram D
    J Exp Med; 2010 Aug; 207(8):1687-99. PubMed ID: 20660613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl11b prevents fatal autoimmunity by promoting T
    Drashansky TT; Helm E; Huo Z; Curkovic N; Kumar P; Luo X; Parthasarathy U; Zuniga A; Cho JJ; Lorentsen KJ; Xu Z; Uddin M; Moshkani S; Zhou L; Avram D
    Sci Adv; 2019 Aug; 5(8):eaaw0480. PubMed ID: 31457080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transcription factor Bcl11b promotes both canonical and adaptive NK cell differentiation.
    Holmes TD; Pandey RV; Helm EY; Schlums H; Han H; Campbell TM; Drashansky TT; Chiang S; Wu CY; Tao C; Shoukier M; Tolosa E; Von Hardenberg S; Sun M; Klemann C; Marsh RA; Lau CM; Lin Y; Sun JC; Månsson R; Cichocki F; Avram D; Bryceson YT
    Sci Immunol; 2021 Mar; 6(57):. PubMed ID: 33712472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl11b prevents the intrathymic development of innate CD8 T cells in a cell intrinsic manner.
    Hirose S; Touma M; Go R; Katsuragi Y; Sakuraba Y; Gondo Y; Abe M; Sakimura K; Mishima Y; Kominami R
    Int Immunol; 2015 Apr; 27(4):205-15. PubMed ID: 25422283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection.
    Dobrzanski MJ; Reome JB; Dutton RW
    J Immunol; 2001 Jul; 167(1):424-34. PubMed ID: 11418679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcl11b represses a mature T-cell gene expression program in immature CD4(+)CD8(+) thymocytes.
    Kastner P; Chan S; Vogel WK; Zhang LJ; Topark-Ngarm A; Golonzhka O; Jost B; Le Gras S; Gross MK; Leid M
    Eur J Immunol; 2010 Aug; 40(8):2143-54. PubMed ID: 20544728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprogramming of T cells to natural killer-like cells upon Bcl11b deletion.
    Li P; Burke S; Wang J; Chen X; Ortiz M; Lee SC; Lu D; Campos L; Goulding D; Ng BL; Dougan G; Huntly B; Gottgens B; Jenkins NA; Copeland NG; Colucci F; Liu P
    Science; 2010 Jul; 329(5987):85-9. PubMed ID: 20538915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Toll-Like Receptor 3 Agonist Polyriboinosinic Polyribocytidylic Acid Increases the Numbers of NK Cells with Distinct Phenotype in the Liver of B6 Mice.
    Salem ML; El-Naggar SA; Mobasher MA; Elgharabawy RM
    J Immunol Res; 2020; 2020():2489407. PubMed ID: 32211442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory NK1.1
    Lin Z; Han S; Qian X; Hu C; Xiao W; Qian L; Zhang Y; Ding Y; Jia X; Zhu G; Gong W
    Cancer Immunol Immunother; 2018 Jul; 67(7):1159-1173. PubMed ID: 29802426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid expression of adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment.
    Cekic C; Day YJ; Sag D; Linden J
    Cancer Res; 2014 Dec; 74(24):7250-9. PubMed ID: 25377469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of intrahepatic CD8+ T cell trapping and NK1.1+ cells in liver-mediated immune regulation.
    Shibolet O; Alper R; Zolotarov L; Trop S; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Clin Immunol; 2004 Apr; 111(1):82-92. PubMed ID: 15093555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depletion of natural killer cells from the graft reduces interferon-gamma levels and lipopolysaccharide-induced tumor necrosis factor-alpha release in F1 hybrid mice with acute graft-versus-host disease.
    Ellison CA; HayGlass KT; Fischer JM; Rector ES; MacDonald GC; Gartner JG
    Transplantation; 1998 Aug; 66(3):284-94. PubMed ID: 9721794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell of origin in radiation-induced premalignant thymocytes with differentiation capability in mice conditionally losing one Bcl11b allele.
    Go R; Hirose S; Katsuragi Y; Obata M; Abe M; Mishima Y; Sakimura K; Kominami R
    Cancer Sci; 2013 Aug; 104(8):1009-16. PubMed ID: 23663453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of IL-15 promotes tumor destruction via NK1.1+ cells in a spontaneous breast cancer model.
    Gillgrass AE; Chew MV; Krneta T; Ashkar AA
    BMC Cancer; 2015 Apr; 15():293. PubMed ID: 25879689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin deficiency suppresses lymphoma growth in mice by modulating NK cells, CD8 T cells, and myeloid-derived suppressor cells.
    Han S; Jeong AL; Lee S; Park JS; Kim KD; Choi I; Yoon SR; Lee MS; Lim JS; Han SH; Yoon DY; Yang Y
    J Immunol; 2013 May; 190(9):4877-86. PubMed ID: 23530146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelopoiesis-associated suppressor-cell activity in mice with Lewis lung carcinoma tumors: interferon-gamma plus tumor necrosis factor-alpha synergistically reduce suppressor cell activity.
    Young MR; Young ME; Wright MA
    Int J Cancer; 1990 Aug; 46(2):245-50. PubMed ID: 2143498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential induction of hematopoiesis and immune suppressor cells in the bone marrow versus in the spleen by Lewis lung carcinoma variants.
    Young MR; Aquino S; Young ME
    J Leukoc Biol; 1989 Mar; 45(3):262-73. PubMed ID: 2522492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells.
    Husain Z; Huang Y; Seth P; Sukhatme VP
    J Immunol; 2013 Aug; 191(3):1486-95. PubMed ID: 23817426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.